So far no bounce but a blood letting. More of the same from this stock. It gets pumped in price and then flipped. Until Gerald puts out a PR with actual meat on it that propels the business forward, we will likely be stuck in this flip cycle. We are most likely back under 10 for the next few weeks if no substantial news comes out.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links
My Agenda: To see Amarantus prosper so I can make a nice return on my investment.